News 11.17.2022 Press Release Kinevant Sciences Announces First Patient Dosed in Phase 2 Study of Namilumab for the Treatment of Pulmonary Sarcoidosis (RESOLVE-Lung) Read More 08.29.2022 Podcast Sarc Fighter: Living with Sarcoidosis and other rare diseases Listen on Apple Podcasts Listen on Spotify
